Vydané akcie spoločnosti 180 Life Sciences
Aká je hodnota metriky Vydané akcie spoločnosti 180 Life Sciences?
Hodnota metriky Vydané akcie spoločnosti 180 Life Sciences Corp. je 40.461M
Aká je definícia metriky Vydané akcie?
Vydané akcie (Shares outstanding) je počet všetkých akcií spoločnosti alebo finančných aktív, ktoré boli autorizované, vydané a kúpené investormi a sú nimi vlastnené.
Shares outstanding includes all stock held by investors including both common shares held by the public and restricted shares owned by the company's internal managements. Shares outstanding have rights and represent an ownership in the corporation by the person who holds the shares. They are distinguished from treasury shares, which are shares held by the corporation itself and have no exercisable rights. Shares outstanding plus treasury shares together amount to the number of issued shares.
Shares outstanding can be calculated as either basic or fully diluted. The basic count is the current number of shares. Dividend distributions and voting in the general meeting of shareholders are calculated according to this number. The fully diluted shares outstanding count, on the other hand, includes diluting securities, such as warrants, capital notes or convertibles. If the company has any diluting securities, this indicates the potential future increased number of shares outstanding. A company's market capitalization is calculated by multiplying the price of one of its shares by the total number outstanding shares a company has issued.
Vydané akcie spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou 180 Life Sciences
Čomu sa venuje spoločnosť 180 Life Sciences?
180 Life Sciences Corp., a clinical-stage biotechnology company, engages in the development of novel drugs for unmet medical needs in chronic pain, inflammation, inflammatory diseases, and fibrosis. Its product development platforms in Phase IIb/III clinical trials include Fibrosis and anti-tumour necrosis factor (Anti-TNF) platform, which focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are man-made derivatives of CBD; and a7nAChR platform, which focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.
Firmy s metrikou vydané akcie podobnou spoločnosti 180 Life Sciences
- Hodnota metriky Vydané akcie spoločnosti Vardhman Special Steels je 40.395M
- Hodnota metriky Vydané akcie spoločnosti Melexis NV je 40.400M
- Hodnota metriky Vydané akcie spoločnosti Franklin Duration Income Trust je 40.405M
- Hodnota metriky Vydané akcie spoločnosti VARTA AG je 40.422M
- Hodnota metriky Vydané akcie spoločnosti Starboard Value Acquisition je 40.424M
- Hodnota metriky Vydané akcie spoločnosti CEAT je 40.450M
- Hodnota metriky Vydané akcie spoločnosti 180 Life Sciences je 40.461M
- Hodnota metriky Vydané akcie spoločnosti QuestEx Gold & Copper je 40.476M
- Hodnota metriky Vydané akcie spoločnosti C-COM Satellite Systems je 40.486M
- Hodnota metriky Vydané akcie spoločnosti 15 Split je 40.494M
- Hodnota metriky Vydané akcie spoločnosti ALX Oncology je 40.500M
- Hodnota metriky Vydané akcie spoločnosti Lancor je 40.500M
- Hodnota metriky Vydané akcie spoločnosti Slate Retail REIT je 40.501M